Research map: Baseline, repeated-measure burden, and two-time-point patterns of the triglyceride-glucose index-visceral lipid ratio (TyG-VLR) and incident cardiovascular disease in cardiovascular-kidney-metabolic (CKM) syndrome stages 0–3: a longitudinal China Health and Retirement Longitudinal Study (CHARLS) analysis

Back to the article

Papers in this map

  1. Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach · Elizabeth R. DeLong · 1988 · 23056 citations · Cited by this paper
  2. Composite metabolic biomarkers for cardiovascular risk assessment in CKM syndrome · Shaun Khanna · 2026 · 1 citation · Cites this paper
  3. Treatment with dapagliflozin and empagliflozin reduces concentrations of N4-acetylcytidine in plasma, a biomarker associated with vascular damage · 2026 · Related
  4. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies · Erik B von Elm · 2008 · 17695 citations · Cited by this paper
  5. Clarifying the role of TyG-VLR in CKM risk characterization: Reply to “Composite metabolic biomarkers for cardiovascular risk assessment in CKM syndrome” · AoMen Lu · 2026 · Cites this paper
  6. Associations of cumulative exposure and dynamic trajectories of the cholesterol–HDL–glucose index and its obesity-related derivatives with cardiovascular disease: a nationwide prospective cohort study · 2026 · Related
  7. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 · Gregory A. Roth · 2020 · 11712 citations · Cited by this paper
  8. Deep learning analysis of ECGs detects Cardiovascular–Kidney–Metabolic syndrome burden in people with diabetes: a report from the Silesia Diabetes-Heart Project · 2026 · Related
  9. Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 · Valery L. Feigin · 2021 · 8115 citations · Cited by this paper
  10. Predicting all-cause and cardiovascular mortality in hypertensive patients by combining the CHG index and its obesity indicators: a prospective cohort study with survival prediction model · 2026 · Related
  11. Cohort Profile: The China Health and Retirement Longitudinal Study (CHARLS) · Yaohui Zhao · 2012 · 5505 citations · Cited by this paper
  12. Divergent mitochondrial and fibrotic signatures in atrial fibrillation: insights from organoids and GEO data · 2026 · Related
  13. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 · Alize J Ferrari · 2024 · 5015 citations · Cited by this paper
  14. STIM1-mediated Treg instability in HFpEF: a new immunological target emerges? · 2026 · Related
  15. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel · Brian A. Ference · 2017 · 4033 citations · Cited by this paper
  16. Joint longitudinal trajectories of the triglyceride-glucose index combined with BMI and waist-to-height ratio and incident cardiovascular disease: a prospective cohort study from the English longitudinal study of ageing · 2026 · Related
  17. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association · Chiadi E. Ndumele · 2023 · 2076 citations · Cited by this paper
  18. Genetically proxied glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor pathway modulation is associated with favorable aging phenotypes: a drug-target Mendelian randomization study · 2026 · Related
  19. Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 · Valery L Feigin · 2024 · 1631 citations · Cited by this paper
  20. Trajectories, cumulative burden of the dynamic triglyceride glucose-Chinese visceral adiposity index, and risk of incident cardiovascular diseases: a large prospective cohort study · 2026 · Related
  21. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement · Ian J. Neeland · 2019 · 1609 citations · Cited by this paper
  22. Optimizing early triage for subclinical cardiovascular-kidney-metabolic syndrome: longitudinal associations, incremental value, and clinical utility of nine insulin resistance surrogates · 2026 · Related
  23. Insulin resistance, cardiovascular stiffening and cardiovascular disease · Michael A. Hill · 2021 · 1111 citations · Cited by this paper
  24. Immunity, atherosclerosis and cardiovascular disease · Johan Frostegård · 2013 · 1068 citations · Cited by this paper
  25. Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019 · Qingfeng Ma · 2021 · 918 citations · Cited by this paper
  26. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020 · Rahul Aggarwal · 2024 · 536 citations · Cited by this paper
  27. Triglyceride–glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies · Xiaobo Ding · 2021 · 525 citations · Cited by this paper
  28. Inflammation in atherosclerosis: pathophysiology and mechanisms · Amir Ajoolabady · 2024 · 430 citations · Cited by this paper
  29. Association of Depressive Symptoms With Incident Cardiovascular Diseases in Middle-Aged and Older Chinese Adults · Haibin Li · 2019 · 407 citations · Cited by this paper
  30. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese · Mingfeng Xia · 2016 · 307 citations · Cited by this paper
  31. Association between the triglyceride glucose-body mass index and future cardiovascular disease risk in a population with Cardiovascular-Kidney-Metabolic syndrome stage 0–3: a nationwide prospective cohort study · Weipeng Li · 2024 · 233 citations · Cited by this paper
  32. Interacting and joint effects of triglyceride-glucose index (TyG) and body mass index on stroke risk and the mediating role of TyG in middle-aged and older Chinese adults: a nationwide prospective cohort study · Rong‐Rui Huo · 2024 · 206 citations · Cited by this paper
  33. Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study · Zenglei Zhang · 2024 · 196 citations · Cited by this paper
  34. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages by Social Determinants of Health · Ruixin Zhu · 2024 · 189 citations · Cited by this paper
  35. The change of triglyceride-glucose index may predict incidence of stroke in the general population over 45 years old · Yaoling Wu · 2023 · 114 citations · Cited by this paper
  36. The interaction between triglyceride-glucose index and visceral adiposity in cardiovascular disease risk: findings from a nationwide Chinese cohort · Yuhao Yang · 2024 · 81 citations · Cited by this paper
  37. Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationwide prospective cohort study · Gaoshu Zheng · 2025 · 81 citations · Cited by this paper
  38. Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study · Lifei Lu · 2025 · 68 citations · Cited by this paper
  39. Dose–response association between Chinese visceral adiposity index and cardiovascular disease: a national prospective cohort study · Yongcheng Ren · 2024 · 64 citations · Cited by this paper

Source: OpenAlex (CC0)